Synovia is a nasty beast [Dissolution / BCS / IVIVC]
Dear all!
The applicant wanted a wavier from Clinical end point study and so they have used a PBPK approach to prove that the levels of free drug in fluid are similar to reference product. As per the article- "The applicant conducted the PSG- recommended in vivo BE study with PK end points but did not perform the PSG- recommended comparative clinical end point study. Instead, the applicant developed a dermal PBPK model for a VBE assessment based on drug exposure at the presumed site of action between the reference and the test products."
The applicant choose- “the most accurate, sensitive, and reproducible approach available among those set forth" which is PK endpoint compared to clinical endpoint.
To further support- Q1, Q2 and Q3 (IVRT and IVPT) were compared against RLD.
Based on all the data- it is acceptable to presume that there is no significant difference between reference drug and applicant formulation. On the same basis- FDA has accepted the application.
Regards,
Dshah
The applicant wanted a wavier from Clinical end point study and so they have used a PBPK approach to prove that the levels of free drug in fluid are similar to reference product. As per the article- "The applicant conducted the PSG- recommended in vivo BE study with PK end points but did not perform the PSG- recommended comparative clinical end point study. Instead, the applicant developed a dermal PBPK model for a VBE assessment based on drug exposure at the presumed site of action between the reference and the test products."
The applicant choose- “the most accurate, sensitive, and reproducible approach available among those set forth" which is PK endpoint compared to clinical endpoint.
To further support- Q1, Q2 and Q3 (IVRT and IVPT) were compared against RLD.
Based on all the data- it is acceptable to presume that there is no significant difference between reference drug and applicant formulation. On the same basis- FDA has accepted the application.
Regards,
Dshah
Complete thread:
- Virtual Bioequivalence: a myth or coming reality? mittyri 2018-06-09 22:39
- Virtual Bioequivalence: a myth or coming reality? jag009 2018-06-13 02:40
- Virtual Bioequivalence: a myth or coming reality? elba.romero 2018-10-19 01:17
- Virtual Bioequivalence: an update from PAGE (+TSD!) mittyri 2019-06-21 13:50
- FDA not concerned about the type I error? Helmut 2019-06-22 18:11
- Virtual Bioequivalence: a myth or coming reality? Helmut 2021-12-23 22:31
- Synovia is a nasty beast mittyri 2021-12-24 13:23
- Synovia is a nasty beastdshah 2022-01-10 15:31
- Synovia is a nasty beast mittyri 2021-12-24 13:23
- Virtual Bioequivalence: a myth or coming reality? Helmut 2022-02-17 12:06